CinRx Pharma Announces Gavin Samuels as Chief Business Officer

CinRx Pharma announced today that Gavin Samuels, M.D., M.B.A has assumed the role of Chief Business Officer.

CinRx Pharma Announces First Study for the Treatment of Obesity

CinRx Pharma announced the first study participant has been dosed in CinFina’s Phase 1 multiple ascending dose (MAD) study of CIN-109.

CinFina Pharma In-Licenses Obesity Portfolio

CinFina Pharma announced that it has signed an agreement with Janssen Sciences.

INVESTOR INQUIRIES

CAREER INQUIRIES

GENERAL INQUIRIES